Effects of Narrative Enhancement and Cognitive Therapy (NECT) on Self-stigma in Patients With Schizophrenia

NCT03967431 | Completed

• 1 other identifier: IRB1070910-02
• Study Type: interventional
• Target: 86
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to explore the effect of narrative enhancement and cognitive therapy in improving self-stigma, self-esteem, depression and hope of patients with chronic schizophrenia.

Conditions

Schizophrenia

Outcome Measures

Primary Outcomes (2)

• The Internalized Stigma of Mental Illness Scale (ISMIS)

  To measure internalized stigma. There are five sub-scales in ISMIS, including Alienation(6 items), Stereotype Experience(7 items), Discrimination Experience(5 items), Social Withdrawal(6 items) and Stigma Resistance(5 items). There are 29 items in this scale. Using Likert scale to rate each item (1=Strongly disagree, 2=disagree, 3=agree, 4=strongly agree) and higher score means higher internalized stigma.

  For two groups at baseline(T0), at 12th week(T1) and at 20th week(T2)

• The Discrimination and Stigma Scale

  To know the experiences of discrimination and stigma. There are four sub-scales in DISC, including Unfair Treatment, Stopping Self, Overcoming Stigma and Positive Treatment. These four sub-scales are independent. Using four point to rate each item(0=not at all, 1=a little, 2=Moderately, 3=A lot) or choose "Not applicable" if the item is not applicable for the subject.

  For two groups at baseline(T0), at 12th week(T1) and at 20th week(T2)

Secondary Outcomes (3)

• Beck Depression Inventory (BDI-II)

  For two groups at baseline(T0), at 12th week(T1) and at 20th week(T2)

• Herth Hope Index (HHI)

  For two groups at baseline(T0), at 12th week(T1) and at 20th week(T2)

• Rosenberg self-esteem scale

  For two groups at baseline(T0), at 12th week(T1) and at 20th week(T2)

Study Arms (2)

Narrative Enhancement and Cognitive Therapy group

EXPERIMENTAL

The patients in the experimental group received narrative enhancement and cognitive therapy which contains 20 times group meetings.

Other: Narrative Enhancement and Cognitive Therapy (NECT)

Control group

NO INTERVENTION

The patients in the control group received routine care.

Interventions

Narrative Enhancement and Cognitive Therapy (NECT) OTHER

Narrative Enhancement and Cognitive Therapy includes two introduction meetings, three psychoeducation meetings, seven cognitive restructuring meetings, seven narrative enhancement meetings and one summing up meeting.

Narrative Enhancement and Cognitive Therapy group

Eligibility Criteria

• Age: 20 Years - 64 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• People with Schizophrenia for more than two years.
• The age is between 20(included) and 64(included).
• Can communicate with Mandarin or Taiwanese.
• The score of the Mini-Mental State Examination (MMSE) is above 24(included).
• The score of the Positive and Negative Syndrome Scale(PANSS) is below 60(included).
• People are willing to participate in this study, can read and know the consent and can sign on the consent by their own.

You may not qualify if:

• Exclude people with a personality disorder, brain injury, cognitive impairment, Intellectual Developmental Disorder or substance use disorder.
• people who are not willing to sign the consent.
• people can not read.
• people can not communicate with Mandarin or Taiwanese.

Sponsors & Collaborators

• National Yang Ming Chiao Tung University: lead

Study Sites (1)

National Yang-Ming University

Taipei, Taiwan

Location

MeSH Terms

Conditions

Schizophrenia

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders

Intervention Hierarchy (Ancestors)

Behavior Therapy; Psychotherapy; Behavioral Disciplines and Activities

Study Officials

• Chiu-Yueh Yang, Ph.D.

  National Yang Ming Chiao Tung University

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: The participants were divided into experimental and control groups through block randomization.

Study Record Dates

• First Submitted: May 27, 2019
• First Posted: May 30, 2019
• Study Start: October 20, 2018
• Primary Completion: July 12, 2019
• Study Completion: July 18, 2019
• Last Updated: August 18, 2020

Record last verified: 2019-07

Data Sharing

• IPD Sharing: Will not share

Locations

TW (1)